Skip to main content
Top
Literature
1.
go back to reference Massasso D, Gibson K (2007) Brucellosis mimicking Henoch-Schönlein purpura. Med J Aust 186:602–603PubMed Massasso D, Gibson K (2007) Brucellosis mimicking Henoch-Schönlein purpura. Med J Aust 186:602–603PubMed
2.
go back to reference Dizbay M, Hizel K, Kilic S, Mutluay R, Ozkan Y, Karakan T (2007) Brucella peritonitis and leucocytoclastic vasculitis due to Brucella melitensis. Braz J Infect Dis 11:443–444PubMedCrossRef Dizbay M, Hizel K, Kilic S, Mutluay R, Ozkan Y, Karakan T (2007) Brucella peritonitis and leucocytoclastic vasculitis due to Brucella melitensis. Braz J Infect Dis 11:443–444PubMedCrossRef
3.
go back to reference Colmenero JD, Reguera JM, Martos F et al (1996) Complications associated with Brucella melitensis infection: a study of 530 cases. Medicine 75:195–211PubMedCrossRef Colmenero JD, Reguera JM, Martos F et al (1996) Complications associated with Brucella melitensis infection: a study of 530 cases. Medicine 75:195–211PubMedCrossRef
4.
go back to reference Kadanali A, Ozkurt Z, Albayrak A, Ertek M, Parlak M (2006) An unusual presentation of acute brucellosis with fever, jaundice and maculopapular rash. Int J Infect Dis 10:409–410PubMedCrossRef Kadanali A, Ozkurt Z, Albayrak A, Ertek M, Parlak M (2006) An unusual presentation of acute brucellosis with fever, jaundice and maculopapular rash. Int J Infect Dis 10:409–410PubMedCrossRef
5.
go back to reference Ariza J, Servitje O, Pallares R et al (1989) Characteristic cutaneous lesions in patients with brucellosis. Arch Dermatol 125:380–383PubMedCrossRef Ariza J, Servitje O, Pallares R et al (1989) Characteristic cutaneous lesions in patients with brucellosis. Arch Dermatol 125:380–383PubMedCrossRef
6.
go back to reference Perez C, Hernandez R, Murie M et al (1999) Relapsing leucocytoclastic vasculitis as the initial manifestation of acute brucellosis. Br J Dermatol 140:1177–1178PubMed Perez C, Hernandez R, Murie M et al (1999) Relapsing leucocytoclastic vasculitis as the initial manifestation of acute brucellosis. Br J Dermatol 140:1177–1178PubMed
7.
go back to reference Nagore E, Sanchez-Motilla JM, Navarro V et al (1999) Leukocytoclastic vasculitis as a cutaneous manifestation of systemic infection caused by Brucella melitensis. Cutis 63:25–27PubMed Nagore E, Sanchez-Motilla JM, Navarro V et al (1999) Leukocytoclastic vasculitis as a cutaneous manifestation of systemic infection caused by Brucella melitensis. Cutis 63:25–27PubMed
8.
go back to reference Catakli T, Arikan FI, Acar B, Dallar Y (2009) Cutaneous vasculitis in a patient with acute brucellosis. Clin Exp Dermatol 34:e387–e388PubMedCrossRef Catakli T, Arikan FI, Acar B, Dallar Y (2009) Cutaneous vasculitis in a patient with acute brucellosis. Clin Exp Dermatol 34:e387–e388PubMedCrossRef
9.
go back to reference Turgay M, Ertuğrul E, Küçükşahin O, Şahin A (2011) Brucellosis with p-ANCA-associated renal failure, leukocytoclastic vasculitis and endocarditis: case report. JMID 1:31–34CrossRef Turgay M, Ertuğrul E, Küçükşahin O, Şahin A (2011) Brucellosis with p-ANCA-associated renal failure, leukocytoclastic vasculitis and endocarditis: case report. JMID 1:31–34CrossRef
10.
go back to reference Mackel SE, Jordon RE (1982) Leukocytoclastic vasculitis: a cutaneous expression of immune complex disease. Arch Dermatol 118:296–301PubMedCrossRef Mackel SE, Jordon RE (1982) Leukocytoclastic vasculitis: a cutaneous expression of immune complex disease. Arch Dermatol 118:296–301PubMedCrossRef
11.
go back to reference Albayrak A, Albayrak F (2011) Hepatic granulomas associated with brucellosis: hepatic granulomas and brucellosis. Hepat Mon 11:1–2PubMedCentralPubMed Albayrak A, Albayrak F (2011) Hepatic granulomas associated with brucellosis: hepatic granulomas and brucellosis. Hepat Mon 11:1–2PubMedCentralPubMed
12.
go back to reference Doganay M, Aygen B (2003) Human brucellosis: an overview. Int J Infect Dis 7:173–182CrossRef Doganay M, Aygen B (2003) Human brucellosis: an overview. Int J Infect Dis 7:173–182CrossRef
13.
go back to reference Metin A, Akdeniz H, Buzgan T, Delice I (2001) Cutaneous findings encountered in brucellosis and review of the literature. Int J Dermatol 40:434–438PubMedCrossRef Metin A, Akdeniz H, Buzgan T, Delice I (2001) Cutaneous findings encountered in brucellosis and review of the literature. Int J Dermatol 40:434–438PubMedCrossRef
14.
go back to reference Albayrak F, Cerrah S, Albayrak A, Dursun H, Yildirim R, Uyanik A (2012) DRESS syndrome with fatal results induced by sodium valproate in a patient with brucellosis and a positive cytoplasmic antineutrophilic cytoplasmic antibody test result. Rheumatol Int 32:2181–2184 Albayrak F, Cerrah S, Albayrak A, Dursun H, Yildirim R, Uyanik A (2012) DRESS syndrome with fatal results induced by sodium valproate in a patient with brucellosis and a positive cytoplasmic antineutrophilic cytoplasmic antibody test result. Rheumatol Int 32:2181–2184
15.
go back to reference Odeh M, Pick N, Oliven A (2000) Deep venous thrombosis associated with acute brucellosis—a case report. Angiology 51:253–256PubMedCrossRef Odeh M, Pick N, Oliven A (2000) Deep venous thrombosis associated with acute brucellosis—a case report. Angiology 51:253–256PubMedCrossRef
Metadata
Title
Two brucellosis cases with vasculitic skin lesions
Authors
Ayse Albayrak
Melek Kadi
Nurhan Döner
Ebru Sener
Publication date
01-04-2014
Publisher
Springer Berlin Heidelberg
Published in
Rheumatology International / Issue 4/2014
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-012-2652-5

Other articles of this Issue 4/2014

Rheumatology International 4/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine